Phase 2 Obesity Trial, Recruiting NCT06582875 Sponsor: University of Colorado, Denver Condition: Obesity
Back to Obesity

Phase 2 Obesity Trial, Recruiting

NCT06582875
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years of age
  • People who have been diagnosed with a specific inherited kidney condition called ADPKD (Autosomal Dominant Polycystic Kidney Disease), confirmed using a standard set of diagnostic criteria
  • People with a body mass index (a measure of body weight relative to height) of 27 or above
  • People whose kidneys are still filtering at a reasonable level (confirmed by a specific blood test result — confirm with trial site)
  • People whose ADPKD has been classified as a certain severity level (Category C, D, or E) based on a kidney ultrasound or MRI scan done within the last 12 months
  • People who are not currently taking part in, or planning to join, any formal weight loss program, structured exercise program, or another medical research study
  • People who are able to give their informed consent to participate

Who may not be able to join:

  • People who have diabetes
  • People who are currently taking, or planning to start, a kidney medication called tolvaptan
  • People who have been hospitalised or had major surgery within the last 3 months
  • People with high blood pressure that is not well controlled (confirm specific numbers with trial site)
  • People who are pregnant, breastfeeding, or unwilling to use appropriate contraception during the trial
  • People who regularly use prescription or non-prescription medications that may affect weight, appetite, food intake, or energy levels
  • People with a history of a clinically diagnosed eating disorder, such as anorexia nervosa, bulimia, or binge eating disorder
  • People whose body weight has changed by more than 5% in the past 3 months for any reason, except weight loss after giving birth
  • People who are unable to have an MRI scan, including those with severe claustrophobia, certain implants or medical devices, or non-removable body piercings
  • People who have had, or currently have, a cancer diagnosis within the past 5 years
  • People with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma), thyroid nodules, or a condition called multiple endocrine neoplasia type 2
  • People with a prior history of pancreatitis (inflammation of the pancreas)
  • People who weigh 450 pounds (approximately 204 kg) or more

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 3037244842

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
6 March 2025
Est. completion
30 June 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in height-Adjusted Total kidney volume

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov